DAPLYZA 10MG TABLET

DAPLYZA 10MG TABLET contains the active ingredient dapagliflozin, which is a medication used to treat type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by inhibiting the reabsorption of glucose in the kidneys, resulting in increased glucose excretion through urine and lowering blood glucose levels. DAPLYZA 10MG TABLET is usually taken orally once daily as directed by a healthcare professional. It is important to note that DAPLYZA 10MG TABLET is typically used in conjunction with a healthy diet and exercise to manage diabetes.

Side Effects:

DAPLYZA 10MG TABLET may cause certain side effects. While not all individuals will experience these side effects, it is important to be aware of them. Common side effects of DAPLYZA 10MG TABLET may include:

1. Genital yeast infections: Dapagliflozin can increase the risk of genital yeast infections in both men and women. Symptoms may include itching, burning, or discharge. It is recommended to maintain good hygiene and seek medical attention if these symptoms occur.
2. Urinary tract infections: Dapagliflozin may increase the risk of urinary tract infections. Symptoms may include frequent urination, pain or burning during urination, or cloudy urine.
3. Increased urination and thirst: Dapagliflozin works by increasing the excretion of glucose in the urine, which may lead to increased urination and thirst.
4. Hypotension (low blood pressure): Dapagliflozin may cause a decrease in blood pressure, leading to symptoms such as dizziness or lightheadedness.

It is important to report any persistent or severe side effects to a healthcare professional.

When Not to Use:

There are certain circumstances when the use of DAPLYZA 10MG TABLET should be avoided. Here are some instances when it is contraindicated:

1. Hypersensitivity: If you have a known hypersensitivity or allergy to dapagliflozin or any other components of the tablet, its use should be avoided.
2. Severe renal impairment: DAPLYZA 10MG TABLET is not recommended for individuals with severe kidney impairment or end-stage renal disease, as it may not be effective in these cases.
3. Diabetic ketoacidosis: DAPLYZA 10MG TABLET should not be used in individuals with diabetic ketoacidosis, a serious complication of diabetes characterized by high blood sugar levels and ketone accumulation.

It is important to discuss your medical history, current medications, and any potential contraindications with a healthcare professional before starting DAPLYZA 10MG TABLET.

Note: This is a general description, and it is essential to consult a healthcare professional or refer to the medication’s package insert for complete and accurate information about DAPLYZA 10MG TABLET, including dosing instructions, precautions, and potential drug interactions.